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Touching up antibodies prevents autoimmunity
Like the first draft of a term paper, the antibody genes of some B cells require revisions. On 
page 2985, Panigrahi et al. show that this genetic editing is faulty in patients with two kinds of 
autoimmune disease. The results could lead to new tests and refined treatments for these diseases.
During development in the bone marrow, maturing B cells reshuffle their antibody genes to 
fashion defenses against a wide variety of pathogens. But these rearrangements can also yield 
antibodies that target self antigens and provoke autoimmune diseases. To forestall misdirected 
attacks, self-targeting B cells often undergo further recombination, known as receptor editing, 
which reshapes their antibody genes.
But receptor editing seems to falter in B cells from patients with autoimmune diseases, 
Panigrahi et al. report. The researchers gauged the amount of rearrangement in a DNA segment 
called RS. Although RS doesn’t code for part of the antibody, rearrangements there reflect the 
cell’s attempts to fix potentially dangerous antibody genes by reshuffling nearby coding segments. 
About 30% of patients with lupus or type I diabetes exhibited abnormally low amounts of RS 
rearrangement, the researchers found. This reduced level of editing might allow self-reactive B 
cells to escape correction and lead to autoimmune attacks.
Immune tolerance can break down at several points, and reduced receptor editing points to a 
flaw that develops before B cells exit the bone marrow. Current autoimmune treatments that 
temporarily deplete B cells are less likely to work in patients with such early-arising problems, the 
researchers suggest, because the number of self-attacking B cells might quickly rebound. Thus, 
measuring levels of RS rearrangement might help doctors tailor treatments for patients and allow 
earlier identification of people prone to autoimmunity.
The benefits of inflamed arteries
Arterial inflammation can lead to hypertension and heart attacks. But it might also have a good 
side, according to Tang et al. (page 3159), permitting vessels to adjust their size to match 
changes in blood flow.
In response to changing demands for blood flow, arteries alter their size to maintain constant 
tension in their walls. They enlarge when more blood is needed, for example in response to organ 
growth; and they narrow when demand for blood flags, such as in the uterine arteries after birth. 
Previous studies had shown that inflammation spurs remodeling of the vessel wall in atherosclerosis 
and hypertension, but whether inflammation also triggered the responses of healthy arteries to 
changes in blood flow was not certain.
To test this idea, the team partially tied off one branch of the carotid artery in mice, cutting 
blood flow by roughly half. Downstream from this obstruction, the artery narrowed by about 
10–15%, and smooth muscle cells disappeared to prevent the vessel wall from thickening. The 
revamping vessel also showed clear signs of inflammation. Cells of the arterial wall churned out 
inflammation-promoting cytokines and chemokines, drawing in macrophages and other 
leukocytes. Destroying the animals’ macrophages thwarted the restructuring.
Neither inflammation nor remodeling could occur without MyD88, an adaptor protein 
necessary for cytokine production in response to IL-1 or Toll-like receptor signals. The researchers 
also discovered that this type of arterial inflammation clears up after about two weeks, which 
might explain why previous studies didn’t detect it.
How Notch heals a broken heart
The Notch pathway helps a developing heart get into shape. Croquelois et al. reveal on page 3173 
that the pathway also helps a damaged heart reshape itself and keep pumping.
Weakened by a heart attack or the protracted stress of hypertension, the heart rebuilds itself as 
it struggles to maintain blood flow. To provide more pumping power, cardiomyocytes swell. 
Some studies suggest that heart stem cells begin proliferating to replace lost cardiomyocytes. 
Because the Notch pathway helps control self-renewal by other organs, Croquelois et al. thought 
it might also have a hand in heart remodeling.
When Notch1 was absent, they found, mice with stressed hearts showed signs of over-
exuberant repair including thicker ventricular walls, increased fibrosis, and more of the telltale 
Patients with lupus and type I diabetes 
have fewer rearrangements in the RS 
region—a marker of receptor editing.
Carotid arteries shrink in response to 
reduced blood flow (right artery).
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Notch1’s absence increases the number of 
suicidal cells (green) in the stressed heart.